share_log

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity Downgrades T2 Biosystems to Hold, Adjusts Price Target to $2.5

Canaccord Genuity 将T2 Biosystems的评级下调至持有,将目标股价调整至2.5美元
Benzinga Real-time News ·  2022/10/14 04:56

Canaccord Genuity analyst Kyle Mikson downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Hold and adjusts the price target from $12.5 to $2.5.

Canaccord Genuity分析师凯尔·米克森将T2 Biosystems(纳斯达克股票代码:TTOO)的评级从买入下调至持有,并将目标股价从12.5美元调整为2.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发